kw.\*:("Sarcolysine")
Results 1 to 25 of 31
Selection :
SYNTHESE ET ETUDE DE L'ACTIVITE ANTITUMORALE DE FRAGMENTS COURTS DE L'HISTONE F2ALPHA 1 ET DE LA RIBONUCLEASE, MODIFIES PAR LA SARCOLYSINERADINA LB; BAEV VV; SOF'INA ZP et al.1976; KHIMIKO-FARM. ZH.; S.S.S.R.; DA. 1976; VOL. 10; NO 8; PP. 6-12; BIBL. 8 REF.Article
ACIDES AMINES ET PEPTIDES. XIV: SYNTHESE ET ACTIVITE ANTITUMORALE DES TRIPEPTIDES ET DE LEURS ANALOGUES RENFERMANT DEUX MOLECULES DE SARCOLYSINEAGADZHANYAN TS E; ARUTYUNYAN AD; MOVSESYAN RA et al.1978; ARM. KHIM. ZH.; SUN; DA. 1978; VOL. 31; NO 11; PP. 862-865; ABS. ARM/ENG; BIBL. 3 REF.Article
DOSAGE DES ANALOGUES DE LA SARCOLYSINE DANS DES COMPRIMESBELOKON OM; KIKOT BS; LOPATIN PV et al.1976; FARMACIJA; S.S.S.R.; DA. 1976; NO 6; PP. 52-55; BIBL. 2 REF.Article
SYNTHESE ET ETUDE DE L'ACTIVITE ANTITUMORALE DE COMPOSES ALKYLANTS CONTENANT DU FERROCENEYASHCHENKO GN; SHASHMURINA AA; ANOSHINA GM et al.1978; KHIMIKO-FARM. ZH.; SUN; DA. 1978; VOL. 12; NO 10; PP. 68-72; BIBL. 8 REF.Article
Cytotoxicity and DNA cross-linking induced by peptide conjugated m-L-sarcolysin in human melanoma cellsHANSSON, J; LEWENSOHN, R; RINGBORG, U et al.Anticancer research. 1991, Vol 11, Num 5, pp 1725-1730, issn 0250-7005Article
MODIFICATION DU NOMBRE DE CELLULES DE LA MOELLE OSSEUSE DE SOURIS AU COURS DE L'ACTION COMBINEE DE L'IRRADIATION A TRES HAUTE FREQUENCE ET DES PREPARATIONS ANTITUMORALESSEVAST'YANOVA LA; VILENSKAYA RL; KUBATKINA EI et al.1974; NAUCH. DOKL. VYSSH. SHK., BIOL. NAUKI; S.S.S.R.; DA. 1974; VOL. 17; NO 8; PP. 55-57; BIBL. 4REF.Article
SCLEROMYXOEDEME D'ARNDT-GOTTRONLEMPERT AS; PANKOV BS; BELOVA GS et al.1978; VEST. DERMATOL. VENEROL.; SUN; DA. 1978; NO 7; PP. 65-68; ABS. ANG; BIBL. 1 P.Article
ETUDE DE L'INFLUENCE DE L'EFFET IMMUNO-DEPRESSIF COMBINE DE LA SARCOLYSINE ET DE L'URETHANE SUR LA CARCINOGENESE INDUITE DANS LES POUMONS CHEZ LA SOURISKRASKOWSKYI GV; KAGAN LF; GARABETS LU et al.1976; VESCI AKAD. NAVUK B.S.S.R., BIJAL. NAVUK; S.S.S.R.; DA. 1976; NO 5; PP. 93-95; BIBL. 16 REF.Article
Differential DNA cross-linking and cytotoxicity in PHA-stimulated human lymphocytes exposed to melphalan, m-L-sarcolysin and peptichemioLEWENSOHN, R; HANSSON, J; RINGBORG, U et al.European journal of cancer & clinical oncology. 1987, Vol 23, Num 6, pp 783-788, issn 0277-5379Article
TRAITEMENT EXPERIMENTAL DE L'ECHINOCOCCOSE. COMMUNICATION. I. MODELES DE LABORATOIRE DE L'ECHINOCOCCOSE ET EFFETS DE LA SARCOLYSINACRIDINE, DU LEVAMISOLE ET DU MEBENDAZOLE SUR LE DEVELOPPEMENT DES LARVOCYSTES DE ECHINOCOCCUS GRANULOSUSKOVALENKO FP; KROTOV AI; BUDANOVA IS et al.1976; MED. PARAZITOL. PARAZIT. BOLEZNI; S.S.S.R.; DA. 1976; VOL. 45; NO 5; PP. 546-551; H.T. 1; ABS. ANGL.; BIBL. 1/2 P.Article
EFFET DE LA GUANINE ET DE LA GUANOSINE-2', 3' PHOSPHATE SUR LA FIXATION DE LA SARCOLYSINE-3H SUR L'ADN DE FOIE DE RATDZHIOEV FK; YAMSHANOV VA.1975; VOPR. ONKOL.; S.S.S.R.; DA. 1975; VOL. 21; NO 4; PP. 37-40; ABS. ANGL.; BIBL. 3 REF.Article
Mutagenic activity of antitumour preparations in conditions of normal and artificial modificationSEMYONOV, V. V.Genetika. 1990, Vol 26, Num 11, pp 2020-2027, issn 0016-6758, 8 p.Article
Selective tumor apoptosis by MF13, L-prolyl-L-m-[bis(chloroethyl)amino]-phenylalanyl-L-norvaline ethyl ester, a new sarcolysin containing tripeptideROBOZ, J; JIANG, J; HOLLAND, J. F et al.Cancer research (Baltimore). 1997, Vol 57, Num 21, pp 4795-4802, issn 0008-5472Article
DNA-DAMAGE IN HUMAN CELLS TREATED WITH THE CLOSELY RELATED ALKYLATING AGENTS PEPTICHEMIO, M-L-SARCOLYSIN AND MELPHALANRINGBORG U; LAMBERT B; LEWENSOHN R et al.1981; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1981; VOL. 17; NO 9; PP. 991-996; BIBL. 17 REF.Article
DETERMINATION DE LA SENSIBILITE INDIVIDUELLE DES TUMEURS GLIALES HUMAINES A DIFFERENTS AGENTS CHIMIOTHERAPIQUESAPSHKALNE DL; KOTEL'NIKOV VM; PURYN'SH I ZH et al.1979; VOPR. NEFROKHIR.; SUN; DA. 1979; NO 4; PP. 30-36; ABS. ENG; BIBL. 17 REF.Article
NOTRE EXPERIENCE DU TRAITEMENT DU MYELOME MULTIPLE ET DE SES COMPLICATIONSABDULKADYROV KM; USHAKOVA EA.1979; PROBL. GEMATOL. PERELIV. KROVI; SUN; DA. 1979; VOL. 24; NO 12; PP. 35-40; ABS. ENG; BIBL. 6 REF.Article
ERYTHROLEUCEMIE ET SARCOLYSINEDE BOCK RFK; PEETERMANS ME.1978; ACTA CLIN. BELG.; BEL; DA. 1978; VOL. 33; NO 1; PP. 23-29; ABS. ENG; BIBL. 38 REF.Article
SYNTHESE DES DERIVES ANALOGUES PEPTIDIQUES DES ACIDES CIS- ET TRANS-AMINO-4 CYCLOHEXANECARBOXYLIQUES COMPORTANT DES RESTES SARCOLYSINEKARPAVICHYUS KI; PATOTSKENE LA; KNUNYANTS IL et al.1978; IZVEST. AKAD. NAUK S.S.S.R., SER. KHIM.; S.S.S.R.; DA. 1978; NO 4; PP. 919-923; BIBL. 5 REF.Article
IN VITRO CYTOTOXICITY OF PEPTICHEMIO COMPARED TO MELPHALAN AND META-DL-SARCOLYSINMORASCA L; ERBA E.1980; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1980; VOL. 16; NO 8; PP. 1105-1109; BIBL. 13 REF.Article
SYNTHESE ET ACTIVITE ANTITUMORALE DE DERIVES N-ACYLES DE LA SARCOLYSINEPAULYUKONIS AB; LAUKAJTIS VA.1976; KHIMIKO-FARM. ZH.; S.S.S.R.; DA. 1976; VOL. 10; NO 5; PP. 23-26; BIBL. 12 REF.Article
Therapeutic effectiveness against MOPC-315 plasmacytoma of low or high doses of the synthetic thymic hormone THF-γ2 in combination with an immunomodulating or a non-immunomodulating drugOPHIR, R; PECHT, M; BURSTEIN, Y et al.International journal of cancer. 1991, Vol 48, Num 1, pp 96-100, issn 0020-7136, 5 p.Article
THE IN VIVO TIME-EFFECT RELATIONSHIP INDUCING CHROMOSOME ABERRATIONS BY THREE CYTOSTATIC DRUGSGEORGIAN L; COMISEL V; GEORMANEANU C et al.1980; REV. ROUMAINE BIOL., BIOL. ANIMALE; ROM; DA. 1980; VOL. 25; NO 1; PP. 59-62; BIBL. 10 REF.Article
EFFECT OF A SARCOLYSIN-CONTAINING POLYMER ON THE LYMPHATIC TISSUES AND IMMUNE RESPONSE TO SHEEP RED BLOOD CELLSKOSTADINOV DA; ANCHEVA MN; POPOV DV et al.1979; BIOMEDICINE; FRA; DA. 1979; VOL. 31; NO 4; PP. 85-86; ABS. FRE; BIBL. 9 REF.Article
Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119)VERLICCHI, F; BOSCHI, S; VISANI, G et al.Blut. 1990, Vol 61, Num 5, pp 311-313, issn 0006-5242, 3 p.Article
SYNTHESES OF 14C-MUSTARD-LABELLED AND 14C-LEUCINE-LABELLED ASALEYFARQUHAR D; LU K; LOO TL et al.1980; J. LABELL. COMPOUNDS RADIOPHARM.; GBR; DA. 1980; VOL. 17; NO 2; PP. 159-170; BIBL. 7 REF.Article